Dynavax Technologies Balans Gezondheid
Financiële gezondheid criteriumcontroles 4/6
Dynavax Technologies has a total shareholder equity of $642.8M and total debt of $223.3M, which brings its debt-to-equity ratio to 34.7%. Its total assets and total liabilities are $1.0B and $373.5M respectively.
Belangrijke informatie
34.7%
Verhouding schuld/eigen vermogen
US$223.27m
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$735.61m |
| Aandelen | US$642.85m |
| Totaal verplichtingen | US$373.47m |
| Totaal activa | US$1.02b |
Recente financiële gezondheidsupdates
Is Dynavax Technologies (NASDAQ:DVAX) Using Debt In A Risky Way?
Oct 12
Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Jul 12Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Recent updates
Is Dynavax Technologies (NASDAQ:DVAX) Using Debt In A Risky Way?
Oct 12Dynavax Technologies: Slow And Steady Wins The Race
Sep 05Dynavax Technologies: A Two Trick Pony Operating With A Single Trick
Aug 23Some May Be Optimistic About Dynavax Technologies' (NASDAQ:DVAX) Earnings
Aug 14Is Dynavax Technologies (NASDAQ:DVAX) Weighed On By Its Debt Load?
Jul 12Lacklustre Performance Is Driving Dynavax Technologies Corporation's (NASDAQ:DVAX) Low P/S
May 22Dynavax: HEPLISAV-B Growth Up, Pipeline Uncertain
May 10Dynavax: Holding Firm Despite Its Missing Cash Cow
Mar 23Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Mar 06Dynavax Technologies Corporation's (NASDAQ:DVAX) Business And Shares Still Trailing The Industry
Jan 31These 4 Measures Indicate That Dynavax Technologies (NASDAQ:DVAX) Is Using Debt Safely
Aug 02Improved Earnings Required Before Dynavax Technologies Corporation (NASDAQ:DVAX) Shares Find Their Feet
Jun 02We Think Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt With Ease
May 03Dynavax Technologies (NASDAQ:DVAX) Seems To Use Debt Rather Sparingly
Jan 16Clover, Dynavax COVID-19 vaccine gets EU GMP certificate
Sep 20Is Dynavax Technologies (NASDAQ:DVAX) A Risky Investment?
Sep 12The Alphavaxers: Dynavax And Novavax, 2 Quarters On
Aug 22Dynavax up 8% after raising full-year guidance for key adjuvant product, Q2 beats
Aug 04Are Investors Undervaluing Dynavax Technologies Corporation (NASDAQ:DVAX) By 41%?
Jun 03Dynavax: Evolving Endemic Situation Adds To Its Risk
May 23Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest
May 12Dynavax Technologies (NASDAQ:DVAX) Could Easily Take On More Debt
May 10Dynavax Technologies: Full Speed Ahead
Mar 01Here's Why Dynavax Technologies (NASDAQ:DVAX) Can Manage Its Debt Responsibly
Jan 28Dynavax: A Coronavirus Growth Story
Jan 17Is Dynavax Technologies Corporation (NASDAQ:DVAX) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 18The Momentum Investor: Spotlight On Dynavax Technologies
Oct 25Analyse van de financiële positie
Kortlopende schulden: DVAX's short term assets ($882.0M) exceed its short term liabilities ($62.2M).
Langlopende schulden: DVAX's short term assets ($882.0M) exceed its long term liabilities ($311.3M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: DVAX has more cash than its total debt.
Schuld verminderen: DVAX's debt to equity ratio has reduced from 1668.3% to 34.7% over the past 5 years.
Schuldendekking: DVAX's debt is not well covered by operating cash flow (17.4%).
Rentedekking: Insufficient data to determine if DVAX's interest payments on its debt are well covered by EBIT.